Apogee Enterprises remains a 'buy' despite revenue drops, due to strong bottom line growth and attractive share pricing ...

Mark Boehme, a worker at Apogee's Viracon factory in Owatonna, inspects a large piece of glass as it moves through processing ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.94% ...

In a recent transaction, Carl Dambkowski, the Chief Medical Officer of Apogee (NASDAQ:APOG) Therapeutics, Inc. (NASDAQ:APGE), sold a significant portion of his holdings in the company. The sale ...

The Pine Channel project lies within the Tantato Domain which is composed of highly deformed gneisses which form the eastern margin of the Archean Rae Craton. Metamorphic rocks which have been subject ...

Apogee Therapeutics Inc (APGE) stock saw a modest uptick, ending the day at $53.34 which represents a slight increase of $2.70 or 5.33% from the prior close of $50.64. The stock opened at $50.64 and ...

Apogee Enterprises, Inc. (Nasdaq: APOG) will report its fiscal 2025 second quarter results on Friday, October 4, 2024, before ...

Companies like Xinyi Glass and Apogee Enterprises are poised to gain from their efforts to capitalize on this demand by ...

In this article we are going to estimate the intrinsic value of Apogee Enterprises, Inc. ( NASDAQ:APOG) by estimating the ...

1 Day 6426 5.77% DJIA 0.59% S&P Mid Cap 400 0.31% Industrial Goods 0.06% ...

SAN FRANCISCO and WALTHAM, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc., (Nasdaq: APGE), a clinical-stage biotechnology company advancing novel biologics with potential for ...

New Heights Tech billionaire and SpaceX space tourist Jared Isaacman and his three fellow crewmates have officially reached ...